These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 11900945)
61. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). Itani KM; Weigelt J; Li JZ; Duttagupta S Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514 [TBL] [Abstract][Full Text] [Related]
62. Linezolid for treatment of vancomycin-resistant enterococcal peritonitis. Bailey EM; Faber MD; Nafziger DA Am J Kidney Dis; 2001 Oct; 38(4):E20. PubMed ID: 11576907 [TBL] [Abstract][Full Text] [Related]
64. Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia. Caffrey AR; Morrill HJ; Puzniak LA; Laplante KL Pharmacotherapy; 2014 May; 34(5):473-80. PubMed ID: 24420846 [TBL] [Abstract][Full Text] [Related]
65. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin. Twilla JD; Finch CK; Usery JB; Gelfand MS; Hudson JQ; Broyles JE J Hosp Med; 2012 Mar; 7(3):243-8. PubMed ID: 22076962 [TBL] [Abstract][Full Text] [Related]
66. [Antibiotics for treatment of infections by methicillin-resistant Staphylococcus aureus (MRSA)]. Stahlmann R Pneumologie; 2014 Oct; 68(10):676-84. PubMed ID: 25290922 [TBL] [Abstract][Full Text] [Related]
67. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains]. Efe S; Sinirtaş M; Ozakin C Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917 [TBL] [Abstract][Full Text] [Related]
68. Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature. Steinmetz MP; Vogelbaum MA; De Georgia MA; Andrefsky JC; Isada C Crit Care Med; 2001 Dec; 29(12):2383-5. PubMed ID: 11801846 [TBL] [Abstract][Full Text] [Related]
69. Use of linezolid in children: an overview of recent advances. Velissariou IM Expert Rev Anti Infect Ther; 2006 Dec; 4(6):947-52. PubMed ID: 17181410 [TBL] [Abstract][Full Text] [Related]
70. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849 [TBL] [Abstract][Full Text] [Related]
71. Rifampin and linezolid in the treatment of methicillin-resistant Staphylococcus aureus preseptal cellulitis. Bababeygy SR; Silva RA; Sun Y; Jain A Ophthalmic Plast Reconstr Surg; 2009; 25(3):227-8. PubMed ID: 19454937 [TBL] [Abstract][Full Text] [Related]
72. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720 [TBL] [Abstract][Full Text] [Related]
73. Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections. Plosker GL; Figgitt DP Pharmacoeconomics; 2005; 23(9):945-64. PubMed ID: 16153136 [TBL] [Abstract][Full Text] [Related]
74. The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia. Chavanet P Med Mal Infect; 2013 Dec; 43(11-12):451-5. PubMed ID: 24238896 [TBL] [Abstract][Full Text] [Related]
75. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium. Till M; Wixson RL; Pertel PE Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739 [TBL] [Abstract][Full Text] [Related]
76. Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. Bates J J Hosp Infect; 1997 Oct; 37(2):89-101. PubMed ID: 9364258 [TBL] [Abstract][Full Text] [Related]
78. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Shaikh ZH; Peloquin CA; Ericsson CD Scand J Infect Dis; 2001; 33(5):375-9. PubMed ID: 11440224 [TBL] [Abstract][Full Text] [Related]
79. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report. Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710 [TBL] [Abstract][Full Text] [Related]
80. Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia. Balli EP; Venetis CA; Miyakis S Antimicrob Agents Chemother; 2014; 58(2):734-9. PubMed ID: 24247127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]